SPRY1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.676600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.305000E-01
Normal-vs-Stage2
4.726200E-01
Normal-vs-Stage3
7.114400E-01
Normal-vs-Stage4
2.583600E-01
Stage1-vs-Stage2
4.565400E-01
Stage1-vs-Stage3
3.599200E-01
Stage1-vs-Stage4
9.908200E-01
Stage2-vs-Stage3
5.767000E-01
Stage2-vs-Stage4
5.273000E-01
Stage3-vs-Stage4
2.897800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.660400E-01
Normal-vs-AfricanAmerican
3.535800E-01
Normal-vs-Asian
9.993000E-01
Caucasian-vs-AfricanAmerican
4.513800E-01
Caucasian-vs-Asian
1.670950E-01
AfricanAmerican-vs-Asian
2.092400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.752600E-01
Normal-vs-Female
3.668400E-01
Male-vs-Female
1.619610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.671600E-01
Normal-vs-Age(41-60Yrs)
3.187800E-01
Normal-vs-Age(61-80Yrs)
5.742800E-01
Normal-vs-Age(81-100Yrs)
6.025400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.135600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.628600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.219000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.895900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.912380E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.995200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.460600E-01
Normal-vs-Daily Drinker
6.990400E-01
Normal-vs-Weekly Drinker
9.277000E-01
Normal-vs-Occasional Drinker
4.161400E-01
Normal-vs-Social Drinker
4.813800E-01
Non Drinker-vs-Daily Drinker
8.254600E-01
Non Drinker-vs-Weekly Drinker
4.170000E-01
Non Drinker-vs-Occasional Drinker
9.024400E-01
Non Drinker-vs-Social Drinker
3.755800E-01
Daily Drinker-vs-Weekly Drinker
5.254200E-01
Daily Drinker-vs-Occasional Drinker
7.243000E-01
Daily Drinker-vs-Social Drinker
3.143600E-01
Weekly Drinker-vs-Occasional Drinker
2.238600E-01
Weekly Drinker-vs-Social Drinker
1.602970E-01
Occasional Drinker-vs-Social Drinker
3.935600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.944600E-01
Normal-vs-Grade 2
1.683850E-01
Normal-vs-Grade 3
1.268410E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.902200E-01
Grade 1-vs-Grade 3
8.895600E-01
Grade 1-vs-Grade 4
2.944600E-01
Grade 2-vs-Grade 3
2.279400E-01
Grade 2-vs-Grade 4
1.683850E-01
Grade 3-vs-Grade 4
1.268410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.982000E-01
Normal-vs-NonDiabetic
5.628200E-01
Diabetic-vs-NonDiabetic
5.997400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.859000E-01
Normal-vs-NoPancreatitis
5.292000E-01
Pancreatitis-vs-NoPancreatitis
7.974000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.960000E-01
Normal-vs-N1
4.563400E-01
N0-vs-N1
9.064600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.502200E-01
Normal-vs-TP53-NonMutant
9.205800E-01
TP53-Mutant-vs-TP53-NonMutant
4.884700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
